Ohio Public Employees Retirement System (OPERS)’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.52M Sell
9,700
-712
-7% -$107K ﹤0.01% 1180
2026
Q1
$1.59M Sell
10,412
-87,109
-89% -$13.4M 0.01% 1155
2025
Q4
$13.4M Buy
97,521
+87,821
+905% +$11.5M 0.04% 368
2025
Q3
$1.24M Hold
9,700
﹤0.01% 1291
2025
Q2
$1.17M Sell
9,700
-88,654
-90% -$9.99M ﹤0.01% 1293
2025
Q1
$11M Buy
98,354
+88,654
+914% +$9.44M 0.04% 398
2024
Q4
$944K Sell
9,700
-173,556
-95% -$18.5M ﹤0.01% 1365
2024
Q3
$21.1M Buy
+183,256
New +$20.8M 0.09% 223
2013
Q4
Sell
-21,204
Closed -$1.46M 1772
2013
Q3
$1.46M Hold
21,204
0.01% 1064
2013
Q2
$1.34M Buy
+21,204
New +$1.38M 0.01% 1011

Other funds holding NVS

Ohio Public Employees Retirement System (OPERS)'s NVS Position: Q2 2026 in Review

Ohio Public Employees Retirement System (OPERS) reduced its Novartis (NVS) stake by 6.8% in Q2 2026, selling an estimated $107K and leaving 9,700 shares worth $1.52M. The position accounts for ﹤0.01% of the portfolio, ranked #1180.

Ohio Public Employees Retirement System (OPERS) first reported a position in NVS in Q2 2013 and has held it in 10 quarters since. The position peaked at $21.1M in Q3 2024. 1,613 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • Ohio Public Employees Retirement System (OPERS) held 9,700 shares of Novartis worth $1.52M as of Q2 2026.
  • Ohio Public Employees Retirement System (OPERS) sold 712 Novartis shares in Q2 2026, an estimated $107K.
  • Novartis made up ﹤0.01% of Ohio Public Employees Retirement System (OPERS)'s portfolio in Q2 2026, its #1180 holding.
  • Ohio Public Employees Retirement System (OPERS) first reported a position in Novartis in Q2 2013 and has held it in 10 quarters since.
  • Ohio Public Employees Retirement System (OPERS)'s Novartis position peaked at $21.1M in Q3 2024.
  • 1,613 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Ohio Public Employees Retirement System (OPERS)'s 13F filing for Q2 2026, filed 17 Aug 2026.